Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Taltz ® (ixekizumab)
Taltz® (Ixekizumab): New Packaging
Changes to the designs of Ixekizumab cartons, labels and leaflets occurred in August 2020. The devices and the manufacturing process have not changed.
The major changes are as follow:1
The pre-filled pen and pre-filled syringe cartons have been redesigned and are slightly longer and wider
The cartons close differently
The location/placement of graphics and printing has been changed slightly
The green backgrounds on the end flap were removed
The Lilly logo design on the pre-filled pen and pre-filled syringe labels has been changed
The location of the batch number and expiration date information has been moved from right to left on the label of the pre-filled pen
Instructions for Use:
1. Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Date of Last Review: November 19, 2020